Inhibitor Therapeutics Inc

Company Snapshot
900 West Platt Street
Tampa, FL 33606-2173
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 6
https://www.inhibitortx.com
Please select from the dropdown
  1. Executive Compensation
  2. > Inhibitor Therapeutics Inc
Company Financials

2018
2019
2020
Gross Profit
Operating Income
-$4,564,257
-$2,747,896
-$1,058,997
Net Income
-$4,550,230
-$2,733,356
-$1,057,929
2018
Gross Profit
Operating Income
-$4,564,257
Net Income
-$4,550,230
2019
Gross Profit
Operating Income
-$2,747,896
Net Income
-$2,733,356
2020
Gross Profit
Operating Income
-$1,058,997
Net Income
-$1,057,929
The above data on Inhibitor Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Robert Harris
President
$191,500
$37,357
$7,816
$236,673
Robert Harris
$236,673
President
Paul D'Sylva
Director
$162,500
$6,250
$16,588
$185,338
Paul D'Sylva
$185,338
Director
James Causey
Director
$13,500
$0
$0
$13,500
James Causey
$13,500
Director
Inhibitor Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2008. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us